TGFB1 and cancer: The TGF-β signaling pathway was frequently downregulated in human cancers (Syed, 2016), whereas this pathway activation could also promote tumorigenesis, metastasis, and chemoresistance (Colak and Ten Dijke, 2017; Zi, 2019).